tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INKT Stock Latest News

MiNK Therapeutics Appoints Dr. John Holcomb as Director
Company AnnouncementsMiNK Therapeutics Appoints Dr. John Holcomb as Director
4d ago
8K
INKT
MiNK Therapeutics appoints John Holcomb to board of directors
PremiumThe Fly
MiNK Therapeutics appoints John Holcomb to board of directors
4d ago
INKT
MiNK Therapeutics appoints Hammond as Head of Inflammatory, Pulmonary Diseases
PremiumThe Fly
MiNK Therapeutics appoints Hammond as Head of Inflammatory, Pulmonary Diseases
15d ago
INKT
Mink Therapeutics’ Earnings Call: Clinical Progress Amid Financial Challenges
PremiumCompany Announcements
Mink Therapeutics’ Earnings Call: Clinical Progress Amid Financial Challenges
1M ago
INKT
Target downgraded, Salesforce upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Target downgraded, Salesforce upgraded: Wall Street’s top analyst calls
2M ago
BJ
PH
MiNK Therapeutics: Promising Clinical Trials and Growth Prospects Lead to Buy Rating
PremiumRatingsMiNK Therapeutics: Promising Clinical Trials and Growth Prospects Lead to Buy Rating
2M ago
INKT
MiNK Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
Premium
The Fly
MiNK Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
2M ago
INKT
MiNK Therapeutics Reports Q2 2025 Milestones and Financials
Premium
Company Announcements
MiNK Therapeutics Reports Q2 2025 Milestones and Financials
2M ago
INKT
MiNK Therapeutics reports Q2 EPS ($1.06) vs (73c) last year
PremiumThe Fly
MiNK Therapeutics reports Q2 EPS ($1.06) vs (73c) last year
2M ago
INKT
Mink Therapeutics, Inc. (INKT) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Mink Therapeutics, Inc. (INKT) Q2 Earnings Cheat Sheet
2M ago
INKT
H.C. Wainwright downgrades MiNK Therapeutics after 400% rally
PremiumThe Fly
H.C. Wainwright downgrades MiNK Therapeutics after 400% rally
3M ago
INKT
MiNK Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
MiNK Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
3M ago
INKT
MiNK Therapeutics announces publication of article on CAR-iNKT in Frontiers
PremiumThe FlyMiNK Therapeutics announces publication of article on CAR-iNKT in Frontiers
3M ago
INKT
MiNK Therapeutics Enters $50M Sales Agreement with B. Riley
Premium
Company Announcements
MiNK Therapeutics Enters $50M Sales Agreement with B. Riley
3M ago
8K
INKT
Why Is MiNK Therapeutics Stock (INKT) Down 30% Today?
Premium
Market News
Why Is MiNK Therapeutics Stock (INKT) Down 30% Today?
3M ago
INKT
MiNK Therapeutics Announces Clinical Trial Success
PremiumCompany Announcements
MiNK Therapeutics Announces Clinical Trial Success
3M ago
8K
INKT
William Blair downgrades MiNK on valuation after 700% rally
PremiumThe Fly
William Blair downgrades MiNK on valuation after 700% rally
3M ago
INKT
Why Is MiNK Therapeutics Stock (INKT) Up 190% Today?
PremiumMarket News
Why Is MiNK Therapeutics Stock (INKT) Up 190% Today?
3M ago
INKT
MiNK Therapeutics downgraded to Market Perform from Outperform at William Blair
PremiumThe Fly
MiNK Therapeutics downgraded to Market Perform from Outperform at William Blair
3M ago
INKT
MiNK data published showing complete remission, says H.C. Wainwright
PremiumThe FlyMiNK data published showing complete remission, says H.C. Wainwright
3M ago
INKT
Promising Clinical Results and Positive Outlook for MiNK Therapeutics’ agenT-797 Drive Buy Rating
Premium
Ratings
Promising Clinical Results and Positive Outlook for MiNK Therapeutics’ agenT-797 Drive Buy Rating
3M ago
INKT
Mink Therapeutics Inc trading resumes
Premium
The Fly
Mink Therapeutics Inc trading resumes
3M ago
INKT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >